Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina
Clinical trial NCT03789552 · RECRUITING
Trial details
- NCT number
- NCT03789552
- Sponsor
- Tasly Pharmaceuticals, Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-01
- Primary completion
- 2026-12-01
- Enrollment
- 765
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.